摘要：5月15日，首届全球心血管大会（Global Cardiovascular Conference，GCC 2025）在北京中关村自主创新示范区展示中心隆重召开。大会颁发了全球心血管创新系列奖项，厦门大学附属心血管病医院（简称“厦心医院”）荣膺“2025全球心血
5月15日，首届全球心血管大会（Global Cardiovascular Conference，GCC 2025）在北京中关村自主创新示范区展示中心隆重召开。大会颁发了全球心血管创新系列奖项，厦门大学附属心血管病医院（简称“厦心医院”）荣膺“2025全球心血管国际合作奖”。
大会由国内心血管领域专业垂直媒体心未来及知名医疗科技媒体思宇MedTech主办，汇聚了来自医疗机构、高校院所、创新企业、投资机构、产业园区的500余名心血管领域专家和代表，聚焦心血管医工合作、技术创新，展开深入探讨和跨界融合，会议现场发布了《2025全球心血管创新年度白皮书》，揭示全球心血管产业市场格局、政策趋势、技术创新、投融资热点和企业生态，为行业发展提供前瞻洞察。
2025全球心血管国际合作奖（2025 Global Cardiovascular International Collaboration Award）旨在表彰成功将中国心血管医疗器械产品推广到其他国家，增强我国心血管医疗器械行业国际影响力，或与国际知名科研机构、医院建立深度合作关系，共同推动心血管医疗器械技术全球发展的心血管企业和相关机构。厦心医院“请进来”与“走出去”相结合的国际医疗合作创新实践荣膺该奖项。
厦心医院办公室主任许良友受邀作为主讲嘉宾，向大会作《创新驱动，走向国际》专题报告，结合厦心医院近年来产业化和国际化发展的探索实践，分享了专科医院打造产业生态圈、拓展国际合作新路径的“厦心模式”。
获奖理由
厦门大学附属心血管病医院通过“请进来”与“走出去”相结合，拓展心血管国际医疗合作，推动中国技术与创新器械走向世界。
“请进来”
厦心医院发起“心苗”访问学者计划，招收国际心血管医师来华培训，项目在联合国总部正式发布并入选国家国际合作发展署全球发展项目库，目前累计接收12个国家23名学员参与培训，为中国技术和产品输出奠定基础。
“走出去”
2024年以来，厦心医院携手国内创新企业赴巴西、萨尔瓦多、印尼等9个国家和地区进行手术指导，完成多例国产器械海外首例植入，组织多场线上手术带教，推介中国原创技术和国产创新器械，持续探索公立医院国际合作助力国产器械出海的新范式。
XMCH Won the GCC 2025 Global Cardiovascular International Collaboration Award
On May 15, the inaugural Global Cardiovascular Conference (GCC 2025) was grandly held at the Zhongguancun Independent Innovation Demonstration Zone Exhibition Center in Beijing. During the conference, a series of Global Cardiovascular Innovation Awards were presented. Xiamen Cardiovascular Hospital Xiamen University (referred to as "XMCH") was honored with the“2025 Global Cardiovascular International Collaboration Award.”
The event was co-hosted by Heart Future, a specialized media platform in the cardiovascular field, and Siyu MedTech, a well known medical technology media outlet. It brought together over 500 experts and representatives from medical institutions, universities, research institutes, innovative enterprises, investment firms, and industrial parks. The conference focused on medical-engineering collaboration and technological innovation in cardiovascular healthcare, fostering in-depth discussions and cross-disciplinary integration. The 2025 Global Cardiovascular Innovation Annual White Paper was released at the event, providing forward looking insights into the global cardiovascular industry, including market landscape, policy trends, technological breakthroughs, investment hotspots, and corporate ecosystems.
The 2025 Global Cardiovascular International Collaboration Award recognizes cardiovascular enterprises and related institutions that have successfully promoted Chinese cardiovascular medical devices internationally enhancing China's global presence in the sector or established deep collaborations with leading international research institutions and hospitals to jointly advance cardiovascular medical technologies worldwide. XMCH was awarded for its innovative international cooperation practices that integrate both“bringing in”and“going out”strategies.
Xu Liangyou, Director of the Office of XMCH, was invited as a keynote speaker and delivered a presentation titled Innovation-Driven, Advancing Internationally. He shared XMCH's experience in building a specialty hospital-centered industrial ecosystem and exploring new avenues for international collaboration, based on its recent progress in industrialization and globalization.
> > Award Rationale
“Xiamen Cardiovascular Hospital Xiamen University has expanded international cardiovascular collaboration by combining ‘bringing in' and ‘going out' strategies, helping Chinese technologies and innovative devices reach the global stage.”
“Bringing In”
XMCH launched the Heart Sapling Visiting Scholar Program, inviting international cardiovascular specialists to China for training. The program was officially announced at the United Nations headquarters and selected into the Global Development Project Pool of the China International Development Cooperation Agency. To date, 23 scholars from 12 countries have participated, laying a solid foundation for the global dissemination of Chinese medical technologies and products.
“Going Out”
Since 2024, XMCH has partnered with domestic innovative enterprises to conduct surgical guidance missions in nine countries and regions, including Brazil, El Salvador, and Indonesia. They successfully performed the first overseas implantation of several domestically developed devices and organized numerous online surgical training sessions, actively promoting original Chinese technologies and homegrown innovations. These efforts exemplify a new model of public hospital-led international cooperation in support of Chinese medical devices entering the global market.
来源：厦大附属心血管病医院
